I believe that the preliminary results of their lead candidate...

I believe that the preliminary results of their lead candidate are very exciting. Of course they seem to be less effective than the comparator used permethrin, however it is still 100% effective and should be a very valuable tool to oppose the rapidly growing resistance to conventional insecticides. This should be even more true when BGT's product is combined with other insecticides to produce a potent synergistic effect. Of course the preliminary results have significantly de-risked the company.

This company has a valuable partnership with Virbac, which should grow stronger in the year ahead, as their is further validation of the technology. I think at these levels, the stock is a straight buy. Speculative it may be, but given the potential upside it's definitely hard to ignore.

DYOR.